Early research (Phase 1)Study completedNCT00003548What this trial is testingAminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal CavityWho this might be right forCancer NYU Langone Health 20
Early research (Phase 1)Study completedNCT00397384What this trial is testingErlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal CancerWho this might be right forAdenocarcinoma of the ColonAdenocarcinoma of the RectumAdvanced Adult Primary Liver Cancer+64 more National Cancer Institute (NCI) 43
Testing effectiveness (Phase 2)Study completedNCT00004911What this trial is testingEndoscopic Placement of Metal Stent in Patients With Cancer-Related Bowel ObstructionWho this might be right forColorectal CancerConstipation, Impaction, and Bowel ObstructionGastric Cancer+4 more Northwestern University
Not applicableStudy completedNCT00372840What this trial is testingPrinted Education Materials in Patients Who Are Finishing Treatment for Stage I, Stage II, or Stage IIIA Breast Cancer, Colorectal Cancer, Prostate Cancer, or Chest CancerWho this might be right forBreast CancerColorectal CancerLung Cancer+4 more Fox Chase Cancer Center 340
Testing effectiveness (Phase 2)Study completedNCT00004910What this trial is testingEndoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal ObstructionWho this might be right forColorectal CancerConstipation, Impaction, and Bowel ObstructionExtrahepatic Bile Duct Cancer+6 more Northwestern University
Early research (Phase 1)Study completedNCT00004074What this trial is testingInterleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/NeuWho this might be right forAdvanced Adult Primary Liver CancerAnaplastic Thyroid CancerBone Metastases+124 more National Cancer Institute (NCI) 15
Post-approval studies (Phase 4)UnknownNCT00274885What this trial is testingRelationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal CancerWho this might be right forCancer GERCOR - Multidisciplinary Oncology Cooperative Group 58
Large-scale testing (Phase 3)WithdrawnNCT04065165What this trial is testingLanreotide Combined With Telotristat Ethyl or Placebo for the First-line Treatment in Patients With Advanced Well Differentiated Small Intestinal Neuroendocrine Tumours (siNET) With Highly-functioning Carcinoid SyndromeWho this might be right forSmall Intestinal NETCarcinoid Heart Disease European Organisation for Research and Treatment of Cancer - EORTC
Not applicableStudy completedNCT00253383What this trial is testingEarly Intervention vs. Standard Palliative Care in Improving End-of-Life Care in Advanced Cancer PatientsWho this might be right forCancer Dartmouth-Hitchcock Medical Center 329
Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Not applicableUnknownNCT05670574What this trial is testingSurgery With Extended (D3) Mesenterectomy for Small Bowel TumorsWho this might be right forSmall Bowel CancerSmall Bowel Carcinoid TumorQuality of Life+2 more Sykehuset i Vestfold HF 150
Large-scale testing (Phase 3)Study completedNCT00016380What this trial is testingOndansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper AbdomenWho this might be right forCancer NCIC Clinical Trials Group 211
Early research (Phase 1)Study completedNCT00031681What this trial is testing7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)Who this might be right forAdvanced Adult Primary Liver CancerCarcinoma of the AppendixEstrogen Receptor-negative Breast Cancer+85 more National Cancer Institute (NCI) 41
Early research (Phase 1)Study completedNCT00005842What this trial is testingTrastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic CancerWho this might be right forCancer National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Study completedNCT05199584What this trial is testingA Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function MutationsWho this might be right forSolid Tumors With PTCH1 Loss-of-function Mutations Endeavor Biomedicines, Inc. 20
Early research (Phase 1)Study completedNCT00654160What this trial is testingIrinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal CancerWho this might be right forAnal CancerCarcinoma of the AppendixColorectal Cancer+9 more Mayo Clinic 7
Testing effectiveness (Phase 2)WithdrawnNCT04672876What this trial is testingTelotristat Ethyl for Reducing Intraoperative Carcinoid Crisis in Patients With Neuroendocrine TumorsWho this might be right forNeuroendocrine Tumors University of Chicago
Early research (Phase 1)Study completedNCT00003867What this trial is testingIrinotecan and Capecitabine in Treating Patients With Solid TumorsWho this might be right forCancer Montefiore Medical Center 30
Large-scale testing (Phase 3)Study completedNCT01578239What this trial is testingA Study Comparing Treatment With 177Lu-DOTA0-Tyr3-Octreotate to Octreotide LAR in Patients With Inoperable, Progressive, Somatostatin Receptor Positive Midgut Carcinoid TumoursWho this might be right forCarcinoid Tumor of the Small BowelNeuroendocrine Tumour Advanced Accelerator Applications 231
Early research (Phase 1)Study completedNCT00003046What this trial is testingInterleukin-12 in Treating Patients With Cancer in the AbdomenWho this might be right forAnal CancerColorectal CancerGallbladder Cancer+2 more M.D. Anderson Cancer Center 29